期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Akkermansia muciniphila: a promising target for the therapy of metabolic syndrome and related diseases 被引量:8
1
作者 ZHOU Ji-Chao ZHANG Xiao-Wei 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2019年第11期835-841,共7页
The probiotic Akkermansia muciniphila(A. muciniphila) is an intestinal bacterium that was first identified in human feces in 2004. Its specialization in mucin degradation makes it a key microorganism that maintains in... The probiotic Akkermansia muciniphila(A. muciniphila) is an intestinal bacterium that was first identified in human feces in 2004. Its specialization in mucin degradation makes it a key microorganism that maintains intestinal mucosal barrier function. As an unique representative strain of the phylum Verrucomicrobia that can be cultured in vitro, A. muciniphila is much easier to detect by metagenomic analysis of intestinal flora. In the past few years, A. muciniphila has been getting increasing attention for the positive correlation between its intestinal colonization and host homeostatic metabolism. In this review, we summarize the relationship between A. muciniphila and host health and diseases, especially focusing on metabolic diseases and related mechanisms, as well as the natural food and drug-derived substrates affecting its colonization in the host, expecting to provide evidence and clues for the development of drugs targeting A. muciniphila. 展开更多
关键词 Gut microbiota Metabolic syndrome DIABETES atural medicine
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部